Skip to main content
. 2020 Mar;9(3):1536–1546. doi: 10.21037/tcr.2020.01.47

Table 2. Adverse reactions of the antiangiogenic treatment group vs. the control group.

Adverse reaction Study No. RR 95% CI P value
Min Max
Hypertension 6 4.88 2.3 10.33 <0.005
Myelosuppression 5 1.36 0.98 1.89 0.067
Vomiting 3 3.66 0.79 16.93 0.097
Anemia 3 0.79 0.45 1.38 0.407
Diarrhoea 3 3.98 1.23 12.87 0.021
Mucositis 3 2.17 0.67 7.04 0.196

RR, risk ratio; CI, confidence interval.